AIXC
AIXC
AIxCrypto Holdings, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 | $7.36M ▲ | $-10.6M ▼ | 0% | $-3.76 ▲ | $-10.24M ▼ |
| Q3-2025 | $0 | $1.43M ▼ | $-2.04M ▼ | 0% | $-4.68 ▼ | $-1.58M ▼ |
| Q2-2025 | $0 | $1.68M ▼ | $-1.69M ▲ | 0% | $-1 ▲ | $-1.58M ▲ |
| Q1-2025 | $0 | $2.72M ▲ | $-2.65M ▼ | 0% | $-1.82 ▼ | $-2.57M ▼ |
| Q4-2024 | $0 | $1.33M | $-855.82K | 0% | $0 | $-749.82K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $19.33M ▼ | $31.28M ▼ | $3.33M ▼ | $27.95M ▼ |
| Q3-2025 | $38.78M ▲ | $43.47M ▲ | $4.92M ▼ | $38.55M ▲ |
| Q2-2025 | $331.6K ▲ | $3.96M ▲ | $5.61M ▲ | $-1.65M ▼ |
| Q1-2025 | $30.21K ▼ | $2.85M ▼ | $2.81M ▲ | $33.13K ▼ |
| Q4-2024 | $1.17M | $4.69M | $2.01M | $2.68M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-10.6M ▼ | $-2.12M ▲ | $-14.07M ▼ | $-3.25M ▼ | $-19.44M ▼ | $-2.12M ▲ |
| Q3-2025 | $-2.04M ▼ | $-2.14M ▼ | $-291K ▲ | $40.88M ▲ | $38.45M ▲ | $-2.14M ▼ |
| Q2-2025 | $-1.69M ▲ | $-1.1M ▲ | $-1.21M ▼ | $2.61M ▲ | $301.39K ▲ | $-1.1M ▲ |
| Q1-2025 | $-2.65M ▼ | $-1.59M ▲ | $-305K ▲ | $750K ▼ | $-1.14M ▼ | $-1.59M ▲ |
| Q4-2024 | $-855.82K | $-2.27M | $-1.01M | $4.06M | $786.46K | $-2.27M |
5-Year Trend Analysis
A comprehensive look at AIxCrypto Holdings, Inc.'s financial evolution and strategic trajectory over the past five years.
AIxCrypto’s main strengths are its strong near‑term liquidity, minimal reliance on debt, and a bold, clearly articulated vision at the intersection of AI, blockchain, and real‑world assets. The strategic backing from Faraday Future provides both validation and an immediate application domain for its technology. The AIxC Hub’s rapid user‑wallet growth indicates early ecosystem traction, and the company’s explicit focus on regulatory compliance could help differentiate it in a space often viewed as risky and unregulated.
The most significant risks are financial and execution‑related. The company currently has no revenue and sizable operating losses, burning cash from operations and investments and relying heavily on equity markets for funding. A long history of accumulated losses underscores this pattern. Strategically, the firm is undergoing a major pivot from biotech to AI and Web3, which brings integration and focus risks. It also operates in highly competitive and fast‑evolving markets, under uncertain regulatory frameworks, where many well‑funded players are pursuing similar ideas. Failure to convert a large, mostly free user base into paying customers would leave the business model unproven.
Near‑term, the outlook is dominated by continued investment, cash burn, and the need for further external funding unless revenue ramps meaningfully. Over the medium term, the company’s prospects depend on whether it can turn its EAI and RWA platforms into commercially adopted products, deepen its partnership ecosystem, and scale its user base into a monetizable network. If execution on the technology and regulatory fronts is successful, the platform could benefit from strong network effects; if not, the combination of high competition and ongoing losses could become increasingly challenging. Overall, uncertainty is high, with considerable upside potential but equally significant operational and financial risk.
About AIxCrypto Holdings, Inc.
https://qlgntx.comAIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $0 | $7.36M ▲ | $-10.6M ▼ | 0% | $-3.76 ▲ | $-10.24M ▼ |
| Q3-2025 | $0 | $1.43M ▼ | $-2.04M ▼ | 0% | $-4.68 ▼ | $-1.58M ▼ |
| Q2-2025 | $0 | $1.68M ▼ | $-1.69M ▲ | 0% | $-1 ▲ | $-1.58M ▲ |
| Q1-2025 | $0 | $2.72M ▲ | $-2.65M ▼ | 0% | $-1.82 ▼ | $-2.57M ▼ |
| Q4-2024 | $0 | $1.33M | $-855.82K | 0% | $0 | $-749.82K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $19.33M ▼ | $31.28M ▼ | $3.33M ▼ | $27.95M ▼ |
| Q3-2025 | $38.78M ▲ | $43.47M ▲ | $4.92M ▼ | $38.55M ▲ |
| Q2-2025 | $331.6K ▲ | $3.96M ▲ | $5.61M ▲ | $-1.65M ▼ |
| Q1-2025 | $30.21K ▼ | $2.85M ▼ | $2.81M ▲ | $33.13K ▼ |
| Q4-2024 | $1.17M | $4.69M | $2.01M | $2.68M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-10.6M ▼ | $-2.12M ▲ | $-14.07M ▼ | $-3.25M ▼ | $-19.44M ▼ | $-2.12M ▲ |
| Q3-2025 | $-2.04M ▼ | $-2.14M ▼ | $-291K ▲ | $40.88M ▲ | $38.45M ▲ | $-2.14M ▼ |
| Q2-2025 | $-1.69M ▲ | $-1.1M ▲ | $-1.21M ▼ | $2.61M ▲ | $301.39K ▲ | $-1.1M ▲ |
| Q1-2025 | $-2.65M ▼ | $-1.59M ▲ | $-305K ▲ | $750K ▼ | $-1.14M ▼ | $-1.59M ▲ |
| Q4-2024 | $-855.82K | $-2.27M | $-1.01M | $4.06M | $786.46K | $-2.27M |
5-Year Trend Analysis
A comprehensive look at AIxCrypto Holdings, Inc.'s financial evolution and strategic trajectory over the past five years.
AIxCrypto’s main strengths are its strong near‑term liquidity, minimal reliance on debt, and a bold, clearly articulated vision at the intersection of AI, blockchain, and real‑world assets. The strategic backing from Faraday Future provides both validation and an immediate application domain for its technology. The AIxC Hub’s rapid user‑wallet growth indicates early ecosystem traction, and the company’s explicit focus on regulatory compliance could help differentiate it in a space often viewed as risky and unregulated.
The most significant risks are financial and execution‑related. The company currently has no revenue and sizable operating losses, burning cash from operations and investments and relying heavily on equity markets for funding. A long history of accumulated losses underscores this pattern. Strategically, the firm is undergoing a major pivot from biotech to AI and Web3, which brings integration and focus risks. It also operates in highly competitive and fast‑evolving markets, under uncertain regulatory frameworks, where many well‑funded players are pursuing similar ideas. Failure to convert a large, mostly free user base into paying customers would leave the business model unproven.
Near‑term, the outlook is dominated by continued investment, cash burn, and the need for further external funding unless revenue ramps meaningfully. Over the medium term, the company’s prospects depend on whether it can turn its EAI and RWA platforms into commercially adopted products, deepen its partnership ecosystem, and scale its user base into a monetizable network. If execution on the technology and regulatory fronts is successful, the platform could benefit from strong network effects; if not, the combination of high competition and ongoing losses could become increasingly challenging. Overall, uncertainty is high, with considerable upside potential but equally significant operational and financial risk.

CEO
Kevin A. Richardson
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-

